Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Infections 2Soft Tissue Infections 1Neutropenia 1Lymphoma, Follicular 1Hot Flashes 1Hematologic Neoplasms 1Fournier Gangrene 1Fever 1Fasciitis, Necrotizing 1

Interventions

pegfilgrastim 3liposomal amphotericin B 2Vancomycin 2Filgrastim 2Caspofungin 2trametinib 1ofatumumab 1dabrafenib 1Teicoplanin 1Tazobactam 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Povidone-Iodine 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Metformin 1Meropenem 1Lenalidomide 1Itraconazole 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Doxorubicin 1Docetaxel 1Daptomycin 1Cyclophosphamide 1Cloxacillin 1Cilastatin, Imipenem Drug Combination 1Ceftazidime 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fever × Daptomycin × Clear all
NCT00335478 2017-05-09

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
54 enrolled 4 charts

Fever, Infections, Neutropenia, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡